cl pharm

CLPharm has been constantly working on the field of edible film tech nology more than 14 years. As a result, we developed our own production line and registered patent on it. We also have certificate on INNO-BIZ(technology innovation small-medium sized company), Venture company, intellectual property star company, ISO 9001 and ISO 14001. CLPharm grafted Flavor Encapsulation technology and Drug Delivery System onto original technology of edible film production that would work effectively on enfant, child, elderly and infirm who have trouble in swallow pills. This technology can also be applied on functional food and we are sole enterprise in the world with this specialized technology.

CLPharm established own laboratory for research and development and put spurs to new product development. Our product is produced in production line that is automated and fulfilled GMP. CLPharm established large scale factory in Chungnam Asan, Korea for a growth to specialized biopharmaceutical company. We are certified as KGMP factory and have strategic partnership with global biopharmaceutical companies to extend our leverage in edible film market. Our capability and potentiality is highly valued in global pharmaceutical industry.

◎Benefits of ODF Business
- Risks of generic development and the R&D expenses can be reduced through joint development and OEM manufacturing and can expect 20~70% profit.
- Cialis is to lose its patent protection in Korea in Sep. 2015 and CL Pharm signed a contract for joint clinical test with four pharmaceutical companies. CL Pharm obtained license in April 10, 2015.
- More than 20 ODF products are under development.
- ODF products help infants who are having hard time taking solid dosage forms. Infants can take medications easily simply by placing film on their tongue with much less resistance.
- It also helps parents when they encourage their children to take medicines. Specially in emergency situations when Children cannot cooperate, ODF could be the fast, easiest, most efficient dosage form.
- Foods, Health supplements, Pharmaceuticals ODF for children are under development : Vitamin, mineral etc. for under 5 years old.
- They can be distributed through various channels and already having positive responses from the buyers.
- Animal ODF products are expected to grow rapidly because of its convenience and increase of companion animal market.
- Idea of developing Animal ODF products has received positive feedbacks during Shanghai Animal drug exhibition.
- ODF for animal has not introduced in the market and it is a good opportunity to achieve dominance in the market.
- CL Pharm is developing many other ODF products through new product development committee and there are many products to be developed as their patents are being expired.
- CL Pharm had meetings in New York last Sep 2014 with staff from UN including Malaria cure project representative regarding Malaria cure in Africa.
- UN supports about 2 billion US$ every year for malaria cure in Africa.
- CL Pharm is preparing for the second meeting with UN and supply contract is to be concluded after clinical test.
- Korean pharmaceutical industry is hit by cheap competition from India and China but ODF technology can bring us future growth
profitability in many countries with its unique technologies in blue ocean markets.